Literature DB >> 9113992

Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells.

F Y Chen1, L C Harris, J S Remack, T P Brent.   

Abstract

O6-Methylguanine-DNA methyltransferase (MGMT), an enzyme that repairs adducts at O6 of guanine in DNA, is a major determinant of susceptibility to simple methylating carcinogens or of tumor response to anticancer chloroethylating drugs. To investigate the mechanisms underlying cellular expression of this DNA repair enzyme, we focused on the role of a 59-bp enhancer of the human MGMT gene in the regulation of its expression. By using chloramphenicol acetyltransferase reporter assays, we found that the enhancer activity, which was present in both MGMT-expressing (Mer+) and -deficient (Mer-) cells, correlated with the endogenous MGMT activity in Mer+ cell lines. Band-shift assays and deletion analysis of the 59-bp sequence defined a minimal 9-mer cis element (5'-CTGGGTCGC-3') for specific trans factor binding. The MGMT enhancer binding protein (MEBP), 45 kDa by Southwestern blot analysis, was present in the nuclei of all Mer+ cells tested but was apparently restricted to the cytoplasm of Mer- cells. We conclude that the MEBP-enhancer interaction plays an important role in regulating constitutive MGMT expression in Mer+ cells and that MEBP exclusion from the nucleus may account for the down-regulation of MGMT in Mer- cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113992      PMCID: PMC20725          DOI: 10.1073/pnas.94.9.4348

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements.

Authors:  D S Prestridge
Journal:  Comput Appl Biosci       Date:  1991-04

Review 2.  Regulation of repair of alkylation damage in mammalian genomes.

Authors:  S Mitra; B Kaina
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1993

Review 3.  Repair of DNA containing O6-alkylguanine.

Authors:  A E Pegg; T L Byers
Journal:  FASEB J       Date:  1992-03       Impact factor: 5.191

4.  Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene.

Authors:  L C Harris; P M Potter; K Tano; S Shiota; S Mitra; T P Brent
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

5.  A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.

Authors:  D C Eustice; P A Feldman; A M Colberg-Poley; R M Buckery; R H Neubauer
Journal:  Biotechniques       Date:  1991-12       Impact factor: 1.993

6.  Ionizing radiation induces O6-alkylguanine-DNA-alkyltransferase mRNA and activity in mouse tissues.

Authors:  R E Wilson; B Hoey; G P Margison
Journal:  Carcinogenesis       Date:  1993-04       Impact factor: 4.944

7.  A comparison of human O6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer- cells.

Authors:  L C Harris; P M Potter; J S Remack; T P Brent
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

8.  The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase.

Authors:  L L Dumenco; E Allay; K Norton; S L Gerson
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

9.  Cytosine methylation and suppression of O6-methylguanine-DNA methyltransferase expression in human rhabdomyosarcoma cell lines and xenografts.

Authors:  M A von Wronski; L C Harris; K Tano; S Mitra; D D Bigner; T P Brent
Journal:  Oncol Res       Date:  1992       Impact factor: 5.574

10.  Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3' untranslated region.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

View more
  7 in total

1.  Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.

Authors:  Edward J Fox; Dermot T Leahy; Robert Geraghty; Hugh E Mulcahy; David Fennelly; John M Hyland; Diarmuid P O'Donoghue; Kieran Sheahan
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 3.  Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research.

Authors:  Guan Jiang; Ai-Jun Jiang; Yong Xin; Lian-Tao Li; Qian Cheng; Jun-Nian Zheng
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

4.  Bortezomib downregulates MGMT expression in T98G glioblastoma cells.

Authors:  Panagiotis J Vlachostergios; Eleana Hatzidaki; Nikolaos E Stathakis; George K Koukoulis; Christos N Papandreou
Journal:  Cell Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.046

5.  SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.

Authors:  Joice Kuroiwa-Trzmielina; Fan Wang; Robert W Rapkins; Robyn L Ward; Daniel D Buchanan; Aung Ko Win; Mark Clendenning; Christophe Rosty; Melissa C Southey; Ingrid M Winship; John L Hopper; Mark A Jenkins; Jake Olivier; Nicholas J Hawkins; Megan P Hitchins
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

6.  Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.

Authors:  Panagiotis J Vlachostergios; Eleana Hatzidaki; Christina D Befani; Panagiotis Liakos; Christos N Papandreou
Journal:  Invest New Drugs       Date:  2013-05-05       Impact factor: 3.850

7.  Antineoplastic effect of decoy oligonucleotide derived from MGMT enhancer.

Authors:  Tamar Canello; Haim Ovadia; Miri Refael; Daniel Zrihan; Tali Siegal; Iris Lavon
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.